h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
LNISi001-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
LNISi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
LNISi001-A (RRID:CVCL_D6IS)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
11th April 2022
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Laboratory of NeuroImmunology (LNIS)
Contact:
Laboratory of NeuroImmunology (LNIS)
Owner
Centre Hospitalier Universitaire Vaudois (CHUV)
Distributors
Centre Hospitalier Universitaire Vaudois (CHUV)
External Databases
BioSamples
SAMEA14029853
Cellosaurus
CVCL_D6IS
Wikidata
Q127382615
General Information
Publications
Perriot S et al. Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines. Stem cell reports. 2018 Nov 13;11(5):1199-1210.
Nishihara H et al. Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2020 Dec;34(12):16693-16715.
Stüdle C et al. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier. Fluids and barriers of the CNS. 2023 Oct 24;20(1):76.
* Is the cell line readily obtainable for third parties?
Yes
Cell line can only be used in: Neurology
Research use:
allowed
Clinical use:
not allowed
Commercial use:
not allowed
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.